These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 35790319)

  • 1. Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria.
    McGill JB; Haller H; Roy-Chaudhury P; Cherrington A; Wada T; Wanner C; Ji L; Rossing P
    BMJ Open Diabetes Res Care; 2022 Jul; 10(4):. PubMed ID: 35790319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practicalities and importance of assessing urine albumin excretion in type 2 diabetes: A cutting-edge update.
    Lalić K; Popović L; Singh Lukač S; Rasulić I; Petakov A; Krstić M; Mitrović M; Jotić A; Lalić NM
    Diabetes Res Clin Pract; 2024 Sep; 215():111819. PubMed ID: 39128565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
    Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
    Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes.
    Rossing P; Groehl F; Mernagh P; Folkerts K; Garreta-Rufas A; Harris J; Meredith K; Carter M; Åkerborg Ö; Wanner C; Hobbs FDR
    J Med Econ; 2023; 26(1):935-943. PubMed ID: 37439218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
    Nichols GA; Déruaz-Luyet A; Brodovicz KG; Kimes TM; Rosales AG; Hauske SJ
    BMC Nephrol; 2020 May; 21(1):167. PubMed ID: 32380961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
    Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of cardiorenal damage: importance of albuminuria.
    Ruilope LM; Ortiz A; Lucia A; Miranda B; Alvarez-Llamas G; Barderas MG; Volpe M; Ruiz-Hurtado G; Pitt B
    Eur Heart J; 2023 Apr; 44(13):1112-1123. PubMed ID: 36477861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of chronic kidney disease in type 2 diabetes: screening, diagnosis and treatment goals, and recommendations.
    Shubrook JH; Neumiller JJ; Wright E
    Postgrad Med; 2022 May; 134(4):376-387. PubMed ID: 34817311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal Early Diagnosis and Monitoring of Diabetic Kidney Disease in Type 2 Diabetes Mellitus: Addressing the Barriers to Albuminuria Testing.
    Christofides EA; Desai N
    J Prim Care Community Health; 2021; 12():21501327211003683. PubMed ID: 33749371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
    Ji E; Kim YS
    Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of chronic kidney disease and screening of renal function in type 2 diabetic patients in Finnish primary healthcare.
    Hagnäs M; Sundqvist H; Jokelainen J; Tumminia A; Vinciguerra F; Loreto C; Frittitta L; Russo GT; Mikkola I
    Prim Care Diabetes; 2020 Dec; 14(6):639-644. PubMed ID: 32527663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for chronic kidney disease in a community-based diabetes cohort in rural Guatemala: a cross-sectional study.
    Flood D; Garcia P; Douglas K; Hawkins J; Rohloff P
    BMJ Open; 2018 Jan; 8(1):e019778. PubMed ID: 29358450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes.
    Filippatos G; Anker SD; Pitt B; Rossing P; Joseph A; Kolkhof P; Lambelet M; Lawatscheck R; Bakris GL; Ruilope LM; Agarwal R
    JACC Heart Fail; 2022 Nov; 10(11):860-870. PubMed ID: 36328655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and awareness of chronic kidney disease among adult diabetic outpatients in Northeast Ethiopia.
    Fiseha T; Tamir Z
    BMC Nephrol; 2020 Apr; 21(1):129. PubMed ID: 32293323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes.
    Buyadaa O; Magliano DJ; Salim A; Koye DN; Shaw JE
    Diabetes Care; 2020 Jan; 43(1):122-129. PubMed ID: 31796570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone.
    Agarwal R; Pitt B; Rossing P; Anker SD; Filippatos G; Ruilope LM; Kovesdy CP; Tuttle K; Vaduganathan M; Wanner C; Bansilal S; Gebel M; Joseph A; Lawatscheck R; Bakris GL
    JAMA Cardiol; 2023 Aug; 8(8):732-741. PubMed ID: 37314801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kidney and cardiovascular outcome trials.
    Bloomgarden Z
    J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.